Page last updated: 2024-09-03

gefitinib and Leiomyosarcoma

gefitinib has been researched along with Leiomyosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biffoni, M; Canzonieri, V; Colarossi, C; D'Andrea, V; De Antoni, E; De Maria, R; Di Matteo, P; Eramo, A; Fecchi, K; Memeo, L; Salvati, V; Sette, G; Signore, M	1

Other Studies

1 other study(ies) available for gefitinib and Leiomyosarcoma

Article	Year
EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential. PloS one, 2012, Volume: 7, Issue:10 Topics: Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gefitinib; Humans; Leiomyosarcoma; Mice; Neoplasm Grading; Neoplastic Stem Cells; Phenotype; Phosphoproteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Vincristine; Xenograft Model Antitumor Assays	2012

Article

Year

EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential.

PloS one, 2012, Volume: 7, Issue:10

Topics: Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gefitinib; Humans; Leiomyosarcoma; Mice; Neoplasm Grading; Neoplastic Stem Cells; Phenotype; Phosphoproteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Vincristine; Xenograft Model Antitumor Assays

2012